Korea Stock: Daewon Pharmaceutical
Company: Daewon Pharmaceutical Company Limited
Bloomberg ticker: 003220 KS
Market cap: US$364m
Background: Daewon Pharmaceutical Company Limited produces and sells pharmaceutical products. The company offers multivitamins, antipyretics, analgesics and anti-inflammatory, gastrointestinal, endocrine, antimicrobial, psychoneurotic, respiratory, cardiovascular, and neuromuscular drugs. Daewon Pharmaceutical is headquartered in Seoul, Korea.
World Class Benchmarking of Daewon Pharmaceutical
(Click on image to enlarge)
- Profitable Growth rank of 3 was same compared to the prior period’s 3rd rank
- This is above average performance compared to 410 medium Health Care companies worldwide
- Profitability rank of 3 was worse than its Growth rank of 2
- Profitability rank of 3 was the same compared to the prior period’s 3rd rank
- This is above average performance compared to peers
- Growth rank of 2 was up compared to the prior period’s 4th rank
- This is World Class performance compared to peers
Disclaimer: I do not know your personal financial situation, so this is not "personalized" investment advice. I encourage you to do your own due diligence on issues I discuss to see if they ...
more
How did you like this article? Let us know so we can better customize your reading experience.
Users' ratings are only visible to themselves.
Comments
Leave a comment to automatically be entered into
our contest to win a free Echo Show.
